988
HETEROCYCLES, Vol. 77, No. 2, 2009
mixture was stirred for 3 h at rt. Then, CH2Cl2 (100 mL) was added and the whole mixture was washed
with 10 % aq. Na2CO3 (50 mL) and with water (50 mL), and dried over Na2SO4. The solvent and
1
pyridine was removed in vacuo to give 5 (6.76 g, 92%). 5: mp 67-68 °C (n-hexane-EtOAc); H NMR
(CDCl3): δ 4.98 (s, 1H, =CH), 3.98 (s, 3H, CH3), 3.92 (s, 3H, CH3); IR (KBr): 1675 (C=O) cm-1. Anal.
Calcd for C6H7F3O3: C, 39.14; H, 3.83. Found: C, 39.16; H, 3.82.
General procedure for the synthesis of 4-methoxy-2-trifluoromethyl-2,3-dihydro-1H-benzo[b][1,4]-
diazepin-2-ols (6a-e’) and 4-methoxy-2-trifluoromethyl-3H-benzo[b][1,4]diazepines (7a-e’).
To a solution of 5 (184 mg, 1.0 mmol) in MeCN (4 mL) was added 1,2-phenylenediamines (1.1 mmol)
and the mixture was stirred for 1 h at rt. The solvent was removed under reduced pressure and the crude
mixture was chromatographed on silica gel column using n-hexane-EtOAc (9:1) as eluent to give 6a-e’
and 7a-e’. In the case with 4-benzoyl-1,2-phenylenediamine, a mixture of 6d and 6d’ and a mixture of
7d and 7d’ were eluted respectively. Similarly, a mixture of 6e and 6e’ and a mixture of 7e and 7e’
were eluted respectively in the case with 4-nitro-1,2-phenylenediamine.
4-Methoxy-2-trifluoromethyl-2,3-dihydro-1H-benzo[b][1,4]diazepin-2-ol (6a): mp 126-127 °C
1
(n-hexane-EtOAc); H NMR (CDCl3): δ 7.10-6.81 (m, 4H, Harom), 4.11 (s, 1H, OH or NH), 3.91 (s, 3H,
OCH3), 3.27 (s, 1H, OH or NH), 2.82 (d, 1H, J = 14.0 Hz, CH2), 2.61 (d, 1H, J = 14.0 Hz, CH2); IR
(KBr): 3326, 3112, 1652 cm-1. Anal. Calcd for C11H11F3N2O2: C, 50.77; H, 4.26; N, 10.77. Found: C,
50.72; H, 4.43; N, 10.65.
4-Methoxy-7,8-dimethyl-2-trifluoromethyl-2,3-dihydro-1H-benzo[b][1,4]diazepin-2-ol (6b): mp
122-123 °C (n-hexane-EtOAc); 1H NMR (CDCl3): δ 6.89 (s, 1H, Harom), 6.62 (s, 1H, Harom), 4.05 (s, 1H,
OH or NH), 3.88 (s, 3H, OCH3), 3.14 (s, 1H, OH or NH), 2.81 (d, 1H, J = 14.0 Hz, CH2), 2.59 (d, 1H, J =
14.0 Hz, CH2), 2.20 (s, 3H, CH3), 2.19 (s, 3H, CH3); IR (KBr): 3321, 3082, 1652 cm-1. Anal. Calcd for
C13H15F3N2O2: C, 54.16; H, 5.24; N, 9.72. Found: C, 54.10; H, 5.01; N, 9.47.
7,8-Dichloro-4-methoxy-2-trifluoromethyl-2,3-dihydro-1H-benzo[b][1,4]diazepin-2-ol
(6c):
mp
117-118 °C (n-hexane-EtOAc); 1H NMR (CDCl3): δ 7.21 (s, 1H, Harom), 6.97 (s, 1H, Harom), 4.21 (s, 1H,
OH or NH), 3.89 (s, 3H, OCH3), 3.17 (s, 1H, OH or NH), 2.84 (d, 1H, J = 14.0 Hz, CH2), 2.63 (d, 1H, J =
14.0 Hz, CH2); IR (KBr): 3315, 3071, 1648 cm-1. Anal. Calcd for C11H9Cl2F3N2O2: C, 40.14; H, 2.76; N,
8.51. Found: C, 40.28; H, 2.74; N, 8.40.
A mixture of (2-hydroxy-4-methoxy-2-trifluoromethyl-2,3-dihydro-1H-benzo[b][1,4]diazepin-
8-yl)phenylmethanone (6d) and (2-hydroxy-4-methoxy-2-trifluoromethyl-2,3-dihydro-1H-
benzo[b][1,4]diazepin-7-yl)phenylmethanone (6d’): 1H NMR (CDCl3): δ 7.74-6.82 (m, 8H, Harom), 4.61
(s, 1H, OH or NH), 4.50 (s, 1H, OH or NH), 3.92, 3.86 (s, 3H, OCH3), 2.89 (d, 1H, J = 14.0 Hz, CH2),
2.73 (d, 1H, J = 14.0 Hz, CH2); IR (KBr): 3372, 3324, 1662, 1646 cm-1. Anal. Calcd for C18H15F3N2O3:
C, 59.34; H, 4.15; N, 7.69. Found: C, 59.49; H, 4.41; N, 8.02.